UK markets closed

Amneal Pharmaceuticals, Inc. (AMRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.06-0.06 (-0.98%)
At close: 04:00PM EDT
5.99 -0.07 (-1.16%)
After hours: 06:30PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate0.090.140.580.66
Low estimate0.080.110.530.54
High estimate0.110.150.630.73
Year ago EPS0.120.190.640.58
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4455
Avg. Estimate618.12M650.37M2.61B2.71B
Low estimate606.75M642M2.59B2.62B
High estimate631.33M655M2.63B2.75B
Year ago sales557.54M599.05M2.39B2.61B
Sales growth (year/est)10.90%8.60%9.00%3.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS0.10.110.130.09
Actual EPS0.120.190.190.14
Difference0.020.080.060.05
Surprise %20.00%72.70%46.20%55.60%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.090.140.580.66
7 days ago0.090.140.580.66
30 days ago0.110.160.60.65
60 days ago0.110.150.580.64
90 days ago0.110.150.580.64
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1N/AN/A1
Up last 30 days1N/A14
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A11N/A
Growth estimatesAMRXIndustrySector(s)S&P 500
Current qtr.-25.00%N/AN/AN/A
Next qtr.-26.30%N/AN/AN/A
Current year-9.40%N/AN/AN/A
Next year13.80%N/AN/AN/A
Next 5 years (per annum)-1.50%N/AN/AN/A
Past 5 years (per annum)7.32%N/AN/AN/A